'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant

Kazuhiro Tateda1, Yoshikazu Ishii, Tetsuya Matsumoto

  • 1Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Ohtaku, Tokyo, Japan. kazu@med.toho-u.ac.jp

Insights

A new

Area of Science:

  • Clinical microbiology and infectious diseases.
  • Antimicrobial resistance research.
  • Pharmaceutical development.

Background:

  • Rising prevalence of multidrug-resistant Pseudomonas aeruginosa (MDRP) poses a significant clinical challenge.
  • Conventional checkerboard assays for antibiotic synergy are time-consuming and labor-intensive, hindering routine clinical application.
  • Need for efficient methods to identify effective antibiotic combinations against resistant bacterial strains.

Purpose of the Study:

  • To develop and evaluate a novel, rapid assay for screening antibiotic combinations against multidrug-resistant organisms.
  • To assess the synergistic effects of antibiotic combinations at clinically relevant concentrations using the new assay.
  • To determine the utility of the 'Break-point Checkerboard Plate' for routine testing against MDRP.

Main Methods:

  • Development of the 'Break-point Checkerboard Plate' assay incorporating breakpoint concentrations (Susceptible 'S', Intermediate 'I') in a microtiter plate format.
  • Testing of 8 different antibiotics, including carbapenem, aminoglycoside, and fluoroquinolone classes.
  • Evaluation of the assay's performance using 12 clinical isolates of MDRP.

Main Results:

  • The 'Break-point Checkerboard Plate' assay successfully identified synergistic effects for certain antibiotic combinations against MDRP strains.
  • Observed synergistic effects were demonstrated at clinically relevant concentrations.
  • The assay proved effective in screening antibiotic combinations for drug-resistant organisms.

Conclusions:

  • The 'Break-point Checkerboard Plate' offers a more efficient alternative to traditional methods for assessing antibiotic synergy.
  • This novel assay is valuable for screening effective antibiotic combinations against challenging multidrug-resistant pathogens like MDRP.
  • The findings support the clinical utility of this assay in guiding antimicrobial therapy for resistant infections.

Related Concept Videos